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Abstract 
Background:  Cashew nut, pistachio nut and mango belong to the Anacardiaceae family and are botanically related. 
Therefore, cashew nut sensitised children are frequently advised to eliminate cashew nuts and pistachio nuts from 
their diet. The ‘Improvement of Diagnostic mEthods for ALlergy assessment (IDEAL trial number NTR3572) study 
showed that cashew nut sensitised children were co-sensitised to pistachio nut in 98% of cases and to mango in 21% 
of cases. The aim of this follow-up study to IDEAL is to assess the clinical relevance of co-sensitisation to pistachio nut 
and mango in cashew nut sensitised children.
Methods: Children were recruited from the study: ‘Improvement of Diagnostic mEthods for ALlergy assessment 
(IDEAL trial number NTR3572). Inclusion criterion for the IDEAL study was sensitization to cashew nut as demon-
strated by either SPT or sIgE, and a clinical history of reactions to cashew nuts or no previous (known) exposure. 
Sensitized children who were tolerant to cashew nuts were excluded. Inclusion criterion for this IDEAL follow-up study 
was co-sensitization to pistachio nut, regardless the result of the DBPCFC with cashew nut. In this follow-up study a 
double-blind placebo-controlled food challenge with pistachio nut and an open food challenge with mango were 
performed.
Results: Twenty-nine children (mean age of 11.6 years, 62% male) were included. Pistachio nut sensitisation was clini-
cally relevant in only 34% of cashew-sensitised children and only 31% of cashew challenge positive children. None of 
the children was challenge positive to mango.
Conclusion: Although co-sensitisation between cashew nut and pistachio nut was observed in 98%, pistachio nut 
sensitisation was only clinically relevant in 34% of the children. Therefore, a challenge test with pistachio nut is recom-
mended in children with cashew nut and pistachio nut sensitisation.
Trial registration The study was registered in the Dutch trial register (registration number 3572) on 10 August 2012 
(retrospectively registered)
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Background
Cashew nut, pistachio nut and mango belong to the 
Anacardiaceae family and are botanically related. 
Cashew nut allergic children are frequently advised to 
eliminate not only cashew nuts, but also pistachio nuts 
from their diet. This advice is based on the sensitisation 
pattern and possible cross-reactivity [1, 2]. Cross-sensi-
tisation between cashew nut and pistachio nut has been 
previously established by specific IgE (sIgE) inhibition 
tests [3–6]. However, studies that confirm clinical cross-
reactivity by performing a challenge are rare [7].
The aim of this follow-up study of the ‘Improvement 
of Diagnostic mEthods for ALlergy assessment (IDEAL) 
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study’ (trial number NTR3572) is to assess the clinical 
relevance of pistachio nut- and mango sensitisation in 
cashew nut sensitised children. The IDEAL-study showed 
that children sensitised to cashew nut were co-sensitised 
to pistachio nut in 98% (169/173) and to mango in 21% 
(37/173).
Methods
Patient selection and study design
Children were recruited from the multi-centre IDEAL-
study and were included between January 2015 and June 
2015. Inclusion criterion for the IDEAL study was sensi-
tization to cashew nut as demonstrated by either SPT or 
sIgE, and a clinical history of reactions to cashew nuts or 
no previous (known) exposure. Sensitized children who 
were tolerant to cashew nuts were excluded. Inclusion 
criterion for this IDEAL follow-up study was co-sensiti-
zation to pistachio nut, regardless the result of the dou-
ble-blind placebo-controlled food challenge (DBPCFC) 
with cashew nut [8]. For practical reasons only two of 
the three centres were invited to participate in this pis-
tachio nut and mango follow-up study. Medical history, 
sensitisation results (sIgE and SPT), and results from 
the DBPCFC with cashew nut were obtained from the 
IDEAL-study. The children underwent a DBPCFC with 
pistachio nut and an open food challenge with mango in 
this follow-up study. Prior to the pistachio and mango 
challenge a dietary history questionnaire was used on 
consumption of pistachio and mango [9] Medical ethi-
cal approval was obtained in January 2015. Parents 
of children (2–12  years old) and parents and children 
(≥12 years old) signed the informed consent.
Skin prick test
All children underwent a SPT in the IDEAL study with 
cashew nut and pistachio nut extract and mango juice, a 
positive control (histamine 10 mg/ml ALK-Abello, Nieu-
wegein, the Netherlands) in duplicate and a negative con-
trol. Cashew nuts (roasted, unsalted) and pistachio nuts 
(fresh, not roasted, unsalted nuts) were homogenized 
mechanically, ground with a mortar and pestle, defatted 
by ether extraction, and subsequently air-dried. A 10% 
w/v extract in phosphate-buffered saline with the pre-
treated material was made. Mango juice was prepared 
from pieces of ripe mango fruit pulp, without skin or 
kernel [8]. The SPT was performed by applying a drop of 
the allergen extract on the skin of the volar aspect of the 
forearm; subsequently the epidermis was punctured with 
a standardised 1 mm sharp tip sterile lancet.
We used a precise scanning method to ascertain the 
SPT results. We divided the area of the allergen-induced 
wheal by the mean area of two positive histamine-
induced wheals. This ratio is defined as HEP-index area. 
A HEP-index area of ≥0.4 corresponding with a wheal 
diameter of ≥3 mm was considered positive [10].
Specific IgE
In the IDEAL study serum samples were analysed for 
sIgE to cashew nut, pistachio nut and mango using the 
Siemens IMMULITE 2000 XPi Immunoassay System 
(Med. Imm. Laboratory; Reinier de Graaf Groep (RdGG). 
Levels above 0.35 kU/l were considered positive.
Challenge tests with cashew nut in the IDEAL study 
and pistachio nut in the follow‑up study
All children underwent a DBPCFC with cashew nut (in 
the IDEAL study) and pistachio nut (follow-up study). 
The food challenge consisted of an eight-step incremen-
tal dose regime. The time interval between each step 
was 30  min. The challenge recipe and dosages used for 
the DBPCFC with pistachio nut were based on vali-
dated and standardised cashew nut recipes used in the 
IDEAL study, and contained the same amount of protein 
equivalent [11]. Roasted unsalted cashew nuts and pis-
tachio nuts were provided by Intersnack, Doetinchem, 
the Netherlands. The food matrix (muffin dough) mainly 
consisted of wheat, sugar, gingerbread spice mix and 
coconut. The challenge dose schedule of the pistachio is 
shown in Table 1. Children under the age of 4 years were 
not required to complete step 8.
Challenge test with mango
Children with no history of symptoms after the con-
sumption of mango were considered non-allergic. The 
remaining children underwent an open challenge (OFC) 
with mango regardless sensitization to mango. The food 
challenge with mango (pieces of fruit without skin or ker-
nel) consisted of a six-step incremental dose regime. The 
challenge dose schedule is shown in Table 1.
Statistical analysis
Statistical analyses were done with the Fisher exact test, 
Mann–Whitney U test and Chi square test. All analyses 
were performed with IBM SPSS Statistics, version 21.
Results
Patient selection
Eighty-five children sensitised to cashew nut and pista-
chio nut, from two of the three participating centres of 
the IDEAL-study were asked to participate in the pista-
chio nut and mango follow-up study. The average period 
between participation in the IDEAL study and this follow 
up study was 24 months. A total of 29 children (34%) par-
ticipated, 38 (45%) did not respond to the invitation, 16 
(19%) refused to participate citing reasons such as that 
the food challenge was time-consuming and burdensome 
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for the child or there was fear for a reaction during 
the challenge. Two children were ultimately excluded 
because they did not receive all interventions.
Patient characteristics and diagnostic results from the 
IDEAL study
Twenty-nine children, 18 boys (62%), mean age of 
11.6  years (range 4–20  years) were included. Symp-
toms, consistent with eczema, asthma or hay fever were 
reported by 15/29 (52%), 7/29 (24%) and 14/29 (48%) of 
the children, respectively. None of the children in this 
group consumed pistachio nuts.
The median cashew nut sIgE was 5.28  kU/l (range 
0.4–100  kU/l) and the median pistachio nut sIgE was 
7.25  kU/l (range 0.6–82  kU/l). The median SPT HEP-
index area of cashew nut and pistachio nut was 2.50 
(range 0–8.8) and 2.02 (range 0–9.4), respectively. Twelve 
of the 29 children were co-sensitised to mango with a 
median sIgE to mango of 0.71 kU/l (range 0–3.76) and a 
median SPT HEP-index area of 0.46 (range 0–1.45).
In order to exclude selection bias, we compared the 
patient characteristics and diagnostic results of the par-
ticipating children (N  =  29) with the non-participating 
children. There was no significant difference in gender 
(p  =  0.80), age (p  =  0.08), asthma (p  =  0.10), eczema 
(p  =  0.52), hay fever (p  =  0.57), sIgE to cashew nut 
(p = 0.85), sIgE to pistachio nut (p = 0.71), SPT cashew 
nut (p = 0.50) and SPT pistachio nut (p = 0.13).
Food challenge with cashew nut (IDEAL study) 
versus pistachio nut (follow‑up study)
The pistachio nut DBPCFC (follow-up study) was posi-
tive in 10/29 (34%) and negative in 19/29 (66%) children 
(Table  2). Most children with a positive DBPCFC with 
pistachio nut experienced ‘oral allergy’ symptoms fol-
lowed by gastro-intestinal symptoms, skin symptoms 
and upper airway symptoms. Eight of ten children expe-
rienced both objective and subjective symptoms and an 
anaphylactic reaction according to the EAACI Guidelines 
for Anaphylaxis [12] occurred in one child.
Of the 29 children, 22 children (76%) had a positive 
challenge with cashew nut (in the IDEAL study) and 7 
children (24%) had a negative challenge with cashew 
nut. Only 9 of the 29 children (31%) had positive chal-
lenge with cashew nut as well as a positive challenge with 
pistachio nut (Table 2). In 6 of the 22 (27%) children, an 
anaphylactic reaction occurred during the cashew nut 
challenge. These 6 children had in all cases a negative pis-
tachio nut food challenge outcome. None of these results 
were statistically significant.
Since the time interval between the cashew nut chal-
lenge and the pistachio nut challenge was rather long 
(median 24  months), it may be argued that the toler-
ance we observed to pistachio nut was due to spontane-
ous tolerance due simply to the passage of time. We thus 
analyzed whether the time between the DFBPCFCs was 
Table 1 Challenge doses DBPCFC with pistachio nut and mango
a The average weight of one pistachio nut was approximately 700 mg, with 23.8 g pistachio protein per 100 g pistachio nuts (Intersnack the Netherlands B.V.)
b 100 g mango (with kernel and peel) contains approximately 1.0 g mango protein
Pistachio  
protein (mg)
Pistachio protein  
cum (mg)
Average amount  
of Pistachio nut
Mango  
protein (mg)
Mango protein  
cum (mg)
Mango  
volume (gr)
Dose 1 1 1 0.007a 3 3 0.3b
Dose 2 3 4 0.02 10 13 1
Dose 3 10 14 0.07 30 43 3
Dose 4 30 44 0.20 100 143 10
Dose 5 100 144 0.67 300 443 30
Dose 6 300 444 2.08 1000 1443 100
Dose 7 1000 1444 6.94 – – –
Dose 8 1736 3180 12.06 – – –
Table 2 Outcome of  the DBPCFC with  cashew nut, pista-
chio nut and OFC with/or home consumption of mango
a 17 children already consumed mango without problems, therefore a 
challenge was not indicated, 1 child declined to undergo the OFC
Outcome DBPCFC pistachio nut Outcome OFC 
mangoa
Positive Negative Total Positive Negative
Outcome DBPCFC cashew
 Positive 9/29 (31%) 13/29 
(45%)
22/29 
(76%)
0 10/11 (91%)
 Nega-
tive
1/29 (3%) 6/29 (21%) 7/29 (24%) 0 1/11 (9%)
Total 10/29 
(34%)
19/29 
(66%)
29 (100%) 11/29 (38%)
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related to tolerance and whether greater proportions of 
negative DBPCFCs were seen with increasing time inter-
vals between the challenges. There was no significant 
correlation between the time between the DBPCFCs 
and the proportion of negative test results to pistachio 
(Spearman correlation coefficient = 0.07, p = 0.7).
Food challenge with mango
Seventeen children already consumed mango without 
problems, therefore a challenge was not indicated. In this 
group 7 (41%) children were sensitized. One declined 
to undergo the OFC because it was time-consuming. In 
total, 11 children participated in the OFC with mango 
and in all cases the challenge was negative. Of this group 
only 4 children (36%) were sensitized.
Food challenge results versus sIgE levels
In patients with a positive challenge to both, cashew 
nut (IDEAL study) and pistachio nut (Follow-up study) 
(n = 9), the median sIgE amounted 10.90 and 17.10 kU/l, 
respectively. Significantly lower median sIgE values were 
found in children reacting to either cashew nut (2.48 kU/l 
or pistachio nut (3.77  kU/l), with p values of 0.014 and 
0.024, respectively.
Discussion
To our knowledge, this is the first study using DBPCFCs 
with pistachio nuts in children to ascertain the clinical 
relevance of co-sensitization to pistachio nut in cashew 
nut sensitized children.
We demonstrated that only one third of the children 
with this co-sensitization to pistachio nuts has a chal-
lenge proven pistachio nut allergy.
The time period of median 24  months between both 
studies is rather long, but the low number of reactors to 
pistachio is not likely to be caused by the development 
of spontaneous tolerance over time, as there was no sig-
nificant association between the time period between the 
challenges and the outcome.
Previous studies reported high percentages of co-sensi-
tisation and cross-sensitisation between cashew nut and 
pistachio nut [1, 3–6, 13–15], however the studies were 
only performed in very small groups, and none of the 
studies performed cashew nut and pistachio nut chal-
lenges. Two case studies on patients with cashew nut-
pistachio nut allergy, investigated cross reactivity between 
the major allergens Ana o 1 from cashew nut and Pis v 3 
(7S vicilin-like protein) [4, 5]. Willison et  al. performed 
inhibition dot- and Western immunoblot assays, and 
found complete cross-reactivity between rAna o 1 and 
rPis v 3 in the serum of cashew/pistachio allergic patients.
To further investigate the cross-reactivity between 
cashew nut and pistachio immunoblot inhibition studies 
are necessary. Although the results in this study suggest 
that cashew nut is the primary sensitizer, we have found 
one patient with a positive pistachio challenge and a nega-
tive cashew challenge, raising possibility that pistachio 
may occasionally be the primary sensitizer. Children with 
an allergy to cashew nut and co-sensitisation to pistachio 
nut are often advised to eliminate both nuts from the diet. 
Based on our results this might not be the best approach. 
Although higher levels of (co-) sensitisation to cashew nut 
and pistachio nut are associated with a higher risk of clini-
cal allergy to these nuts, a DBPCFC is clearly indispensable 
for making a definitive diagnosis in individual patients.
Apart from the need for a well-established diagnosis, 
unnecessary avoidance of pistachio nuts or mango may 
have other disadvantages. Unnecessary lengthy elimina-
tion of allergenic foods in sensitised patients can increase 
the risk of a severe allergic reaction after accidental 
intake of the allergen [15].
In conclusion, this is the first multi-centre study in 
patients sensitised to cashew nut investigating the clini-
cal relevance of co-sensitisation to pistachio nut and 
mango with food challenges. The percentage of clinical 
relevant co-sensitisation was low (34%) for pistachio nut 
and absent for mango in this study population. Oral food 
challenges are recommended in order to avoid unnec-
essary avoidance of pistachio nut in cashew nut allergic 
patients.
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